World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON  MA, ELMWOOD PARK, NJ, and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, […]

SAN JOSE & NEW YORK – Complete Genomics and Basepair, Inc today announced a technology integration partnership to accelerate the analysis and interpretation of genomic data generated by Complete Genomics’ DNBSEQ™ sequencing platforms. The partnership gives Complete Genomics’ customers seamless access to Basepair’s bioinformatics platform deployed on Amazon Web Services (AWS) and use its easy-to-use […]

Company Releases Mastermind 3.0 with the Clinical Exome Fully Curated at the Gene Level Genomenon Inc., a leading genomic intelligence company, today announced the first milestone in its journey to curate the human genome with the release of Mastermind 3.0, now including the clinical exome fully curated at the gene level. With this latest launch of […]

Partnerships Maximize Value of HiFi Data and Complete the Full End-to-End Workflow for PacBio Customers. MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the addition of two tertiary analysis partners to PacBio Compatible. Geneyx and Golden Helix will enable PacBio customers to leverage PacBio HiFi data for disease research with the Revio, […]

Newly formed partnership enables clinical genomics laboratories to move from sample to evidence-backed analysis to actionable clinical reports using a push-bottom solution. Washington, DC. — Fabric Genomics, the leader in AI-powered clinical next generation sequencing (NGS) interpretation and reporting, today announced a strategic collaboration with cloud-based data management pioneer DNAnexus to empower hospitals, clinical laboratories, and academic centers […]

The partners will offer an integrated sample-to-report rapid nanopore sequencing analysis platform for neonatal/paediatric intensive care units to support clinicians in acute settings OXFORD, England — Oxford Nanopore Technologies plc (Oxford Nanopore), the nanopore-sequencing company delivering unparalleled rich genomic data insights, and Fabric Genomics, the leading AI-driven analysis and interpretation software provider, today announced a […]

Oxford, UK – OGT, A Sysmex Group Company and leading global provider of clinical research solutions, and Intelliseq, a genome informatics company, are delighted to announce the release of GeneSpect™ Somatic Reporter for use with OGT’s SureSeq™ portfolio of next generation sequencing (NGS) panels. This advanced analytical reporting solution pairs state-of-the-art variant interpretation and reporting with […]

This new partnership will provide integrated end-to-end solutions from sample to report for whole genome nanopore sequencing in future clinical applications. OXFORD, United Kingdom — Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Saphetor, the next generation sequencing data analysis company, today announce a new […]

Company appoints Jon Murray as VP Sales, Colleen McMillen as VP Marketing, and Dave Anstey as VP Pharma Business Development Ann Arbor, MI — Genomenon®, Inc., a leading genomic intelligence company, has announced new executive appointments for its sales and marketing team as the company continues to expand its footprint across clinical diagnostics and pharmaceutical markets. These […]

BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces a strategic partnership with NTT in Japan to accelerate data-driven medicine. This collaboration will introduce a national medical data distribution platform to integrate, curate, and harmonize Japanese healthcare data. The primary goal of the partnership is to provide a positive impact on patients […]